INTRODUCTION
THE LAST comprehensive report on ionizing radiation exposure of the U.S. population from all sources was published by National Council on Radiation Protection and Measurements (NCRP) in 1987 (NCRP 1987 . This was followed by another report in 1989 (NCRP 1989) that included supporting data relative to medical exposure. Both of those reports included data only up through 1982. In the fall of 2006, the NCRP established a scientific committee (SC 6-2) to review the current state of knowledge and prepare a new report on the magnitude of all sources of radiation exposure to the U.S. population. A medical subgroup was included as part of the committee to specifically examine the changes that had occurred over the last 25 y.
Specific tasks of the medical subgroup included estimating the current number and types of medical procedures using ionizing radiation and evaluating the effective dose per procedure as well as annual per capita effective dose and annual collective effective dose. Additional tasks included evaluating past and potential future trends. Modalities or applications to be examined included standard radiography and fluoroscopy, interventional procedures (including cardiology), mammography, computed tomography (CT), dental, nuclear medicine, and radiotherapy. The information gained was intended for use by individuals, manufacturers, practitioners, and regulators. The preliminary results of the work of the NCRP 6-2 medical subgroup are presented here. NCRP will publish a full report on exposure of the U.S. population to ionizing radiation. Readers are encouraged to obtain a copy of this report from NCRP.
MATERIALS AND METHODS
Data were derived from both primary and secondary sources. The primary sources on national utilization included Medicare claims data for about 40 million subscribers during 2004 as well as commercially available benchmarking reports for various modalities from IMV (Information Means Value) Limited (IMV 2004 (IMV , 2005 (IMV , 2006 . The IMV reports cover both hospital and nonhospital sites and the surveys typically obtained responses from one-half to two-thirds of all imaging sites in the U.S.
The data provided information on the total numbers of general categories of examinations. Distribution of specific types of examinations within a category was primarily derived from Medicare payment data, since it supplied specific Current Procedural Terminology (CPT) billing codes. Secondary utilization sources included 2006 data from the U.S. Veterans Administration, claims data from a large national employer's insurance plan, and data from the Agency for Healthcare Quality and Research. When data were only available for years prior to 2006, the previous annual growth rate was used to estimate the 2006 frequency of procedures.
Data on exposure and absorbed dose were obtained from a number of sources. These included specific surveys from the National Exposure X-ray Trends (NEXT) of the U.S. Food and Drug Administration (FDA), data from accreditation surveys of the American College of Radiology, and exposure data from surveys in several states. For radiographic and fluoroscopic procedures, the published literature on absorbed and effective doses from various examinations was reviewed and collated to obtain a best estimate. Effective doses for nuclear medicine studies were obtained from International Commission on Radiological Protection (ICRP) models (ICRP 1998) . In some circumstances additional data were obtained from commercial sources and for some examinations the committee performed its own calculations and measurements. Collective dose was obtained by multiplying the estimated number of examinations nationally by the effective dose per specific CPT code or an average for a group of CPT codes.
There were a number of assumptions and issues inherent in collection and evaluation of the data. It was assumed that benefit exceeds risk for most medical procedures and no attempt was made to address this issue. There was no single complete data source set and various incomplete data sets were used and compared and crosschecked with each other to obtain a fairly complete picture of the number and frequency of the major types of procedures. When crosschecking was not possible, the combination and interpolation of incomplete datasets was assumed to be a reasonable representation of the situation. Finally, effective dose was estimated using a radiation weighting factor of one for photons of all energies.
RESULTS
The number of procedures, collective dose and per capita dose for the various modalities for 2006 are shown in Table 1 . Inspection of the table indicates that CT and nuclear medicine account for only 22% of procedures but about 75% of the collective effective dose. Although the number of dental radiography procedures is difficult to estimate (probably about 500 million) the contribution to effective dose is small. Table 2 presents information on the various subgroups of standard radiography procedures. The vast majority of the dose comes from examinations of the pelvis, hips, spine and upper gastrointestinal (GI) tract. Table 3 presents data on the frequency and dose from various types of CT procedures. There were an estimated 62 million procedures, but since some CT procedures involve multiple scans the total number of scans in 2006 was estimated to be 67 million. The annual number of CT procedures from 1993-2006 is shown in Fig. 1 . The number of CT procedures increased at an annual rate of over 10%, while the U.S. population increased at less than 1% annually. Scans of the chest, abdomen and pelvis account for about two-thirds of the collective effective dose. CT scans are relatively high dose and CT scanning resulted in an annual collective effective dose of about 440,000 person-Sv and an annual per capita dose of about 1.5 mSv. Table 4 presents information on various types of diagnostic nuclear medicine procedures. Annual growth in patient visits from 1995-2005 is shown in Fig. 2 and corresponds to an annual growth rate of 5%. In 2005, it was estimated that there were about 19.7 million procedures during 17.2 million patient visits. There has been extremely rapid growth of cardiac nuclear medicine effective dose has increased from about 124,000 person-Sv to about 900,000 person-Sv, or by 700%.
DISCUSSION
The estimates of effective dose presented here are average for the U.S. population. While average doses for a given examination have been used, individual dose for a specific examination may vary substantially and often ranges up to an order of magnitude (Fig. 3) (Stern et al. 2001 † † † ). In addition, the per capita dose reflects all examinations done in the U.S. and the number of the U.S. population. Of course, the majority of persons do not get an x-ray or nuclear medicine examination each year and some patients get many examinations and will receive a much higher effective dose than the per capita dose.
There are a number of uncertainties in any evaluation of medical population exposure. These are somewhat difficult to accurately quantitate but probably do not affect final estimates by more than about 30% based upon the variation in the data from different sources. The factors include, but are not limited to, extrapolation and interpolation of the various source data sets as well as estimation of exposure factors, absorbed dose, and effective dose.
The committee has used a radiation weighting factor of 1.0 for medical x rays and nuclear medicine procedures (i.e., photons of all energies) as is required by the current formulation of effective dose (ICRP 1991) . The 2005 Biological Effects of Ionizing Radiation (BEIR) VII committee report (NRC 2005) indicated that a higher relative biological effectiveness (RBE) value might be appropriate for low energy photons. NCRP may reexamine the appropriate value for the radiation weighting factor for photons in the future. The ICRP has recently approved new recommendations which will change the overall set of tissue weighting factors, particularly, lowering the value assigned to gonads and increasing the value assigned to female breast (ICRP 2007) . These changes would decrease effective doses for examinations of the pelvis and increase effective doses for procedures which expose the chest; however, overall, the changes are estimated to be small compared to other uncertainties present in population dose estimates.
Estimation of detriment utilizing effective dose assumes a general population structure. As a result it is important to evaluate the age structure of the medically exposed population and compare it to the general U.S. population. The data for age distribution of CT scans are shown in Fig. 4 where it is evident that the age structure is different for the age distribution of CT scans compared to the general population.
It is instructive to compare magnitude of the annual collective effective dose (900,000 person-Sv) from medical devices in the U.S. with other global man-made sources. For example, the global annual collective effective dose from fallout is estimated to be less than 30,000 person-Sv and the global annual occupation collective † † † Stern SH, Kaczmarek RV, Spelic DC, Suleiman OH. Nationwide evaluation of x-ray trends ( effective dose is estimated to be less than 5,000 person-Sv (UNSCEAR 2000). The United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) has estimated that the total worldwide estimate for collective effective dose over all time from the Chernobyl accident is less than 500,000 person-Sv. doses range between 0.7 and 2.0 mSv (Regulla and Eder 2005; Shannoun et al. 2006) .
Currently, there is conversion of film screen radiographic examinations to digital format including computed radiography (CR) and direct digital radiography (DDR). The effect of these technologies on dose has been the subject of a number of publications. While digital techniques have the potential to reduce doses, in general doses with CR tend to be higher than film screen and for DDR are usually somewhat lower. At the present time, the effect of these technological conversions in standard radiology is felt to be relatively minor especially given the magnitude of doses from other modalities, in particular CT and nuclear medicine.
Future trends are likely to show a further increase in medical exposure for several reasons. The U.S. population is aging and will require more medical care. In addition, it is clear as of 2006 that CT scanning is the largest source of medical exposure. Dose and examination frequency data from the newer, faster 256-slice multidetector CT scanners, which are currently being installed, are not yet available. These new CT scanners may allow for markedly increased application of high dose procedures such as CT coronary angiograms.
CONCLUSION
The estimates of the NCRP Scientific Committee 6-2 medical subgroup are that in 2006 the per capita dose from medical exposure (not including dental and radiotherapy) has increased almost 600% to about 3.0 mSv and the collective dose has increased over 700% to about 900,000 person-Sv. The largest contributions and increases have come primarily from CT scanning and nuclear medicine. The 67 million CT scans account for 15% of the total medical radiation procedures and about 50% of collective dose. Nuclear medicine accounts for about 4% of all procedures but 26% of the total collective dose. Medical radiation exposure is now approximately equal to natural background radiation.
